Similarly, our finding also noted an increase in the phosphorylation of CHK1 and CDC25c after the inhibition of AURKB by barasertib treatment, which mimicked the phenotypical response of KDM5D knockdown in platinum-tolerant HNSCC cells. Here, KDM5D is linked to head and neck squamous cell carcinoma.